PEGS CELEBRATES RECORD ATTENDANCE FOR THE TENTH CONSECUTIVE YEAR!
PEGS: The Essential Protein
Engineering Summit, the industry’s
preeminent event that inspires accelerated biotherapeutic protein drug
development, delivered a week of networking,
learning and inspiration in Boston’s thriving seaport district.
For the tenth consecutive year, PEGS Boston saw record growth with over 2,500 industry professionals in attendance. PEGS announced it will be returning to Boston next year April 8-12. Continue to check the website for details and call for speaker proposals.
Over
the course of the week, the conference hosted a total of more than 400
lectures, panels, tutorials and round-table discussions, along with more than
150 exhibitors, and 300 research posters on display in the exhibit hall.
The lineup of distinguished faculty included some of the
industry’s leading experts, visionaries, and influencers from top pharma,
biotech, academia, and government institutions including Abbott Labs, AbbVie,
Adimab, Amgen, AstraZeneca, Biogen, Celgene, Harvard University, Memorial Sloan
Kettering Cancer Center, MIT, NIH, Novartis, Novo Nordisk, Pfizer, Sanofi, St.
Jude Children’s Research Hospital, and many more.
PLENARY KEYNOTES
Challenges and Opportunities in Engineering Protein Biopharmaceuticals
K. Dane Wittrup, PhD,
C.P. Dubbs Professor, Chemical Engineering and Biological Engineering; Associate Director, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT)/em>
YOUNG SCIENTIST KEYNOTE
The Next Generation of Cancer Immunotherapy: Targeting Myeloid Immune Checkpoints
Kipp Weiskopf, MD, PhD,
Resident Physician, Internal Medicine, Brigham and Women’s Hospital